semaglutide banned Hims & Hers' Super Bowl ad turns up the heat on GLP-1 battle Will Compounded Semaglutide Be Banned?
Description
Semaglutide is a GLP-1 receptor agonist originally developed to treat type 2 diabetes that clinical trials have shown reduces body weight by an average of 15% over 68 weeks when combined with lifestyle modifications
How to Start Your Journey with Hormone Fitness Begin your journey to better health and restful sleep by booking a consultation with us today
It is also prescribed off-label by healthcare providers for chronic weight management in adults who are obese or overweight with at least one weight-related comorbidity
Patients aged 75 Years Old or Older The reduced cardiovascular and renal morbimortality associated with the use of GLP-1 RAs is beneficial for this particularly risky population [68,69,70,71,72,73]
